Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Short term Debt: 2010-2024

Historic Short term Debt for Lifecore Biomedical (LFCR) over the last 15 years, with May 2024 value amounting to $773,000.

  • Lifecore Biomedical's Short term Debt changed negligibly% to $773,000 in Q4 2024 from the same period last year, while for Nov 2024 it was $773,000, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $773,000 for FY2024, which is 33.28% up from last year.
  • According to the latest figures from FY2024, Lifecore Biomedical's Short term Debt is $773,000, which was up 33.28% from $580,000 recorded in FY2023.
  • In the past 5 years, Lifecore Biomedical's Short term Debt ranged from a high of $98.2 million in FY2022 and a low of $580,000 during FY2023.
  • Its 3-year average for Short term Debt is $33.2 million, with a median of $773,000 in 2024.
  • As far as peak fluctuations go, Lifecore Biomedical's Short term Debt soared by 238.54% in 2022, and later slumped by 99.41% in 2023.
  • Over the past 5 years, Lifecore Biomedical's Short term Debt (Yearly) stood at $77.4 million in 2020, then tumbled by 62.53% to $29.0 million in 2021, then spiked by 238.54% to $98.2 million in 2022, then slumped by 99.41% to $580,000 in 2023, then surged by 33.28% to $773,000 in 2024.